Aubagio FDA Approved Drugs
14mg (oral tablet)
7mg (oral tablet)
Sanofi Aventis UsSep 12, 2012
- Treatment of patients with relapsing forms of multiple sclerosis while managing the risk of teriflunomide and rosuvastatin interaction by limiting the rosuvastatin dose to no more than 10mg and/or administering about half the normal dose.
- Treatment of patients with relapsing forms of multiple sclerosis.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.